Joyce T J, Yood R A, Carraway R E
Department of Physiology, University of Massachusetts Medical School, Worcester 01655.
J Clin Endocrinol Metab. 1993 Sep;77(3):632-7. doi: 10.1210/jcem.77.3.7690359.
Substance-P (SP) and its metabolites, SP-(1-7) and SP-(5-11), were quantitated in arthritic synovial fluids and plasma using a validated procedure. This process involved collection into appropriate enzyme inhibitors, extraction with acid-acetone, high pressure liquid chromatography, and RIA using region-specific antisera. Our results demonstrate that the levels of authentic SP in these fluids are less than 3.5 pmol/L, which is 50- to 10,000-fold less than those previously reported by others. These discrepant findings were not attributable to degradation, because added SP was recovered in good yield, and the measured levels of the metabolites SP-(1-7) and SP-(5-11) were also extremely low. In search of an explanation, we noted that many of the earlier reports involved direct assay of these fluids (without extraction and chromatography). Further work indicated that proteolytic enzymes (e.g. protease 24.11) present in these unextracted fluids can give rise to artifactually high SP measurements. We conclude that if SP is released within the joint space and if it participates in the inflammatory reaction and/or healing process, it most likely does so in a local fashion, which would not involve its accumulation in synovial fluid or plasma.
采用一种经过验证的方法,对关节炎滑液和血浆中的P物质(SP)及其代谢产物SP-(1-7)和SP-(5-11)进行定量分析。该过程包括收集到合适的酶抑制剂中,用酸丙酮萃取,高压液相色谱法,以及使用区域特异性抗血清进行放射免疫分析。我们的结果表明,这些液体中真实SP的水平低于3.5 pmol/L,这比其他人之前报道的水平低50至10000倍。这些不一致的发现并非由于降解所致,因为添加的SP回收率良好,且代谢产物SP-(1-7)和SP-(5-11)的测量水平也极低。为了寻找解释,我们注意到许多早期报告涉及对这些液体的直接检测(未进行萃取和色谱分析)。进一步的研究表明,这些未萃取液体中存在的蛋白水解酶(如蛋白酶24.11)可导致SP测量值出现人为的升高。我们得出结论,如果SP在关节腔内释放,并且如果它参与炎症反应和/或愈合过程,那么它很可能以局部方式发挥作用,这并不涉及它在滑液或血浆中的积累。